Suchergebnisse - "Moser, Tina"

PubPharm (20)

1

Surpassing sensitivity limits in liquid biopsy

enthalten in: Science (New York, N.Y.) | 2024

von Moser, T. | Heitzer, E.

2

Bridging biological cfDNA features and machine learning approaches

enthalten in: Trends in genetics : TIG | 2023

von Moser, T. | Kühberger, S. | Lazzeri, I. | +2

3

Comprehensive characterisation of cell-free tumour DNA in plasma and urine of patients with renal tumours

enthalten in: bioRxiv.org | 2022

von Smith, C. | Moser, T. | Burge, J. | +30

4

Clinical implementation of plasma cell-free circulating tumor DNA quantification by digital droplet PCR for the monitoring of Ewing sarcoma in children and adolescents

enthalten in: Frontiers in pediatrics | 2022

von Seidel, M. | Kashofer, K. | Moser, T. | +7

5

Dynamic Changes of Circulating Tumor DNA Predict Clinical Outcome in Patients With Advanced Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors

enthalten in: JCO precision oncology | 2021

von Weber, S. | van der Leest, P. | Donker, H. | +15

ErratumIn: JCO Precis Oncol. 2022 Jan;6:e2100566. - PMID 35025621

6

Somatic Copy-Number Alterations in Plasma Circulating Tumor DNA from Advanced EGFR-Mutated Lung Adenocarcinoma Patients

enthalten in: Biomolecules | 2021

von Buder, A. | Heitzer, E. | Waldispühl-Geigl, J. | +7

7

A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study

enthalten in: International journal of cancer | 2021

von Unseld, M. | Belic, J. | Pierer, K. | +9

8

Molecular profiling of soft-tissue sarcomas with FoundationOne® Heme identifies potential targets for sarcoma therapy : a single-centre experience

enthalten in: Therapeutic advances in medical oncology | 2021

von Scheipl, S. | Brcic, I. | Moser, T. | +12

9

A higher ctDNA fraction decreases survival in regorafenib‐treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study

enthalten in: International Journal of Cancer | 2021

von Unseld, M. | Belic, J. | Pierer, K. | +9

10

Inference of tumor cell-specific transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection of cancer

enthalten in: bioRxiv.org | 2020

von Ulz, P. | Perakis, S. | Zhou, Q. | +18